Cargando…
A highly annotated database of genes associated with platinum resistance in cancer
Platinum-based chemotherapy, including cisplatin, carboplatin, and oxaliplatin, is prescribed to 10-20% of all cancer patients. Unfortunately, platinum resistance develops in a significant number of patients and is a determinant of clinical outcome. Extensive research has been conducted to understan...
Autores principales: | Huang, Dongqing, Savage, Sara R., Calinawan, Anna P., Lin, Chenwei, Zhang, Bing, Wang, Pei, Starr, Timothy K., Birrer, Michael J., Paulovich, Amanda G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602037/ https://www.ncbi.nlm.nih.gov/pubmed/34645978 http://dx.doi.org/10.1038/s41388-021-02055-2 |
Ejemplares similares
-
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer
por: Huang, Dongqing, et al.
Publicado: (2021) -
Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance
por: Ferriss, J. Stuart, et al.
Publicado: (2012) -
GeneDB—an annotation database for pathogens
por: Logan-Klumpler, Flora J., et al.
Publicado: (2012) -
CPLM 4.0: an updated database with rich annotations for protein lysine modifications
por: Zhang, Weizhi, et al.
Publicado: (2021) -
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
por: Chowdhury, Shrabanti, et al.
Publicado: (2023)